
Alzheimer's Association International Conference (AAIC) 2026
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Alzheimer's Association International Conference (AAIC) 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
Alzheimer’s Association International Conference (AAIC 2026)
Event type: Neurology, Alzheimer’s research, dementia care, pharmaceuticals, biotech, diagnostics, clinical trials, healthcare, academic research, medical innovation
Estimated attendance: Typically a large global medical and scientific gathering with several thousand attendees, including researchers, clinicians, pharmaceutical professionals, biotech teams, academic institutions, healthcare innovators, nonprofits, and policy stakeholders. Final attendance will depend on the 2026 program, but this event is widely recognized as one of the most important international meetings in dementia and Alzheimer’s research.
This conference is a high-value B2B and scientific networking event because it brings together the people who influence research funding, drug development, diagnostics, patient care, clinical adoption, and institutional purchasing. For attendee-list selling, this event is most valuable when you focus on decision-makers and commercial stakeholders rather than only general attendees.
1) Who attends: buyers / attendees
The audience is a mix of scientific, clinical, commercial, and institutional buyers. The event is not a consumer show; it is a deep professional ecosystem around brain health, neurodegeneration, and aging-related care. The strongest buyer segments usually include pharmaceutical and biotech companies, diagnostics companies, medical device firms, research institutions, hospitals, universities, CROs, and healthcare service providers.
Typical attendee groups include:
- Neurologists, geriatricians, psychiatrists, and memory-care clinicians
- Principal investigators, research directors, and laboratory heads
- Pharmaceutical R&D leaders and clinical development teams
- Biotech executives focused on CNS, neurodegeneration, and biomarkers
- Clinical trial operations teams and CRO professionals
- Hospitals, memory clinics, and academic medical centers
- Diagnostics, imaging, and digital health solution providers
- Nonprofit organizations, advocacy groups, and policy stakeholders
- Investors, business development teams, and partnership managers
- Medical education, publishing, and scientific communications companies
2) Where the show is happening + attendee geographic origin
The location for AAIC 2026 should be confirmed from the official event website because venue and city may change by year. Historically, this conference draws an international audience regardless of host city. It is one of those events where the geographic spread is a major advantage for list value.
Attendee origin pattern:
- Global scientific and clinical audience
- Strong representation from the United States, Canada, the United Kingdom, Germany, France, the Netherlands, Japan, South Korea, Australia, and other major research markets
- Broad participation from academic centers, hospitals, biotech clusters, and pharmaceutical hubs
- International policy, nonprofit, and advocacy participation
If your client is targeting this audience, geography matters less than role and research focus. The best contacts are usually tied to institutions with active budgets, trials, product development, or procurement authority.
3) Audience reach
Reach type: Global
This conference is not local or regional. It has a strong international reach and attracts professionals from multiple continents. The buyer list value is high because the event concentrates specialized professionals who are difficult to reach through general marketing channels.
This global reach is especially important for clients selling:
- Clinical trial services
- Biomarker and diagnostic platforms
- Research tools and lab technologies
- Imaging systems and analytics
- Digital cognition, AI, and data platforms
- Pharmaceutical and biotech services
- Healthcare education, publishing, and scientific communications
4) Sample buyer company names + websites
Below is a sample buyer table with companies that are likely to be relevant to this event. These are selected for fit with Alzheimer’s, dementia, neurology, clinical research, diagnostics, healthcare innovation, and life sciences commercialization.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Biogen | biogen.com | VP Clinical Development / Director, Neuroscience Partnerships | Major neuroscience company with strong relevance to Alzheimer’s research, biomarkers, and therapeutic development. |
| 2 | Eli Lilly and Company | lilly.com | Director, Neurodegeneration Research / Clinical Program Lead | Large pharma buyer active in dementia and brain-health therapeutic areas. |
| 3 | Roche | roche.com | Head of Neurology Marketing / Clinical Science Lead | Strong diagnostics and pharma footprint; relevant for Alzheimer’s biomarkers and clinical studies. |
| 4 | Novartis | novartis.com | Medical Affairs Director / Neuroscience Strategy Lead | Global pharma organization with strong medical affairs and research interest in CNS innovation. |
| 5 | AbbVie | abbvie.com | Director, Clinical Development / Therapeutic Area Head | Potential fit for neurodegeneration, aging-related research, and healthcare partnerships. |
| 6 | Pfizer | pfizer.com | Senior Manager, Medical Strategy / Clinical Research Director | Large life sciences buyer with strong conference interest in research, trials, and collaboration. |
| 7 | Johnson & Johnson | jnj.com | Neuroscience Business Development Manager / Medical Affairs Director | Broad healthcare footprint with research and strategic partnership potential. |
| 8 | Takeda | takeda.com | Director, Global Clinical Operations / Medical Science Liaison Lead | Strong life sciences organization with global clinical and therapeutic-area interests. |
| 9 | Thermo Fisher Scientific | thermofisher.com | Product Marketing Manager / Head of Neuroscience Solutions | Research tools, lab solutions, and diagnostics are highly relevant to Alzheimer’s researchers. |
| 10 | Siemens Healthineers | siemens-healthineers.com | Director, Neurology Imaging Solutions / Clinical Sales Director | Excellent fit for imaging, diagnostics, and clinical workflow technologies. |
| 11 | GE HealthCare | gehealthcare.com | Segment Marketing Manager / Clinical Applications Leader | Relevant for imaging, digital diagnostics, and clinical technology adoption. |
| 12 | IQVIA | iqvia.com | VP, Clinical Research Services / Business Development Director | Strong CRO and real-world evidence buyer for research, analytics, and trial operations. |
| 13 | Labcorp | labcorp.com | Director, Biomarker Strategy / Clinical Trials Partnerships Manager | Relevant for diagnostics, biomarkers, and research services supporting Alzheimer’s studies. |
| 14 | Quest Diagnostics | questdiagnostics.com | Senior Director, Specialty Testing / Medical Affairs Manager | Good fit for diagnostics, testing, and biomarker commercialization. |
| 15 | Medtronic | medtronic.com | Director, Neurotechnology Strategy / Clinical Marketing Lead | Relevant if the client sells devices, neurotechnology, or healthcare solutions. |
| 16 | Fujirebio | fujirebio.com | Business Unit Director / Neuroscience Diagnostics Manager | Highly relevant to Alzheimer’s biomarker and in-vitro diagnostic activity. |
| 17 | Quest Diagnostics | questdiagnostics.com | Director, Innovation Partnerships / Clinical Product Manager | Good buyer for lab testing, biomarker development, and healthcare partnerships. |
| 18 | McKesson | mckesson.com | VP, Healthcare Solutions / Strategic Accounts Director | Useful buyer for healthcare distribution, solutions, and institutional partnerships. |
| 19 | Otsuka Pharmaceutical | otsuka-us.com | Medical Director / Neuroscience Portfolio Lead | Strong healthcare and CNS relevance with interest in clinical and therapeutic innovation. |
| 20 | Horizon Therapeutics | horizontherapeutics.com | Brand Director / Medical Affairs Manager | Good fit for specialty pharma and healthcare stakeholder engagement. |
Top 5 best sample accounts to send first: Biogen, Eli Lilly and Company, Roche, Thermo Fisher Scientific, IQVIA. These are the strongest combinations of scientific relevance, buying intent, and conference alignment.
5) Job profiles, industries & event type
This is a specialized event, so job-title targeting is more important than broad industry targeting. The best leads are usually senior or mid-senior stakeholders who control budgets, partnerships, research direction, or solution evaluation.
Best job profiles to target:
- Director of Neuroscience Research
- Head of Clinical Development
- Medical Affairs Director
- VP, Research & Development
- Clinical Operations Manager
- Biomarker Program Lead
- Director, Translational Medicine
- Neurology Marketing Manager
- Scientific Affairs Manager
- Business Development Director
- Partnerships Manager
- Product Manager, Diagnostics
- Director, Precision Medicine
- Laboratory Director
- Research Program Manager
- Director, Digital Health
- Clinical Trial Operations Lead
- Medical Science Liaison
Best industries from your industry list:
- Biotechnology
- Pharmaceuticals
- Hospital & Health Care
- Medical Devices
- Research
- Information Services
- Information Technology & Services
- Health, Wellness & Fitness
- Higher Education
- Education Management
- Medical Practice
- Mental Health Care
- Philanthropy
- Nonprofit Organization Management
- Market Research
- Professional Training & Coaching
6) Estimated attendance / expected footfall
Estimated attendance is likely to be in the several-thousand range, with a highly qualified mix of scientific and commercial attendees. The value is not just the size of the audience, but the concentration of senior professionals in a very specific disease area.
What this means for attendee-list buyers:
- High concentration of niche decision-makers
- Strong participation from organizations with budgets and active research agendas
- Excellent for B2B outreach, sponsored introductions, event follow-up, and scientific marketing
- Useful for lead generation in pharma, biotech, diagnostics, and healthcare technology
7) Key focus areas & buyer engagement
The conference focuses on Alzheimer’s disease, dementia, neurodegeneration, brain health, biomarkers, patient care, early diagnosis, treatment innovation, and translational research. Buyer engagement is strongest around scientific relevance and clinical utility.
Key focus areas:
- Alzheimer’s and dementia research
- Biomarkers and early detection
- Clinical trials and trial design
- Neuroimaging and diagnostics
- Drug discovery and therapeutic pipelines
- Cognitive assessment and digital health
- Care delivery and patient support
- Public health, aging, and policy
- Real-world evidence and data analytics
Best engagement angles:
- “Reach leaders working on dementia, biomarker innovation, and clinical development.”
- “Target pharma, biotech, diagnostics, and academic research decision-makers in one place.”
- “Connect with professionals shaping Alzheimer’s research, treatment pathways, and healthcare adoption.”
8) Client-product fit note
To recommend the best buyers from this conference, I need your client website or product page first. The right list depends heavily on what your client sells.
Examples:
- If your client sells clinical trial services, focus on pharma, biotech, CROs, and research institutions.
- If your client sells diagnostics or biomarkers, focus on labs, imaging companies, diagnostic firms, and medical research teams.
- If your client sells software or data platforms, focus on digital health leaders, research analytics teams, and hospital innovation groups.
- If your client sells medical devices or healthcare technology, focus on hospital systems, neurology departments, and academic medical centers.
- If your client sells publishing, education, or communications services, focus on scientific publishers, associations, nonprofits, and research communications teams.
Please share the client website, and I can review it and give you the best buyer targets based on exact product-market fit.
9) Final recommendation
This is a strong event for attendee-list sales if your buyer definition is precise. It is especially valuable for clients operating in neuroscience, biotech, pharma, diagnostics, clinical research, healthcare technology, and medical communications.
Best buyer segments to collect:
- Pharma and biotech research leaders
- Diagnostics and biomarker companies
- Clinical trial and CRO teams
- Academic researchers and medical centers
- Healthcare technology and imaging firms
- Medical education, publishing, and scientific service providers
Quality rating for attendee-list sales: 9/10
This event is highly specialized, global, and scientifically valuable. It is one of the better conference types for premium B2B targeting because the audience is built around active research, innovation, and healthcare purchasing influence.
Data sheet
| Event Name | Alzheimer's Association International Conference (AAIC) 2026 |
| Event Date | 12–15 July 2026 |
| Event Status | Upcoming |
| Venue | ExCeL London |
| City | London |
| State / Region | England |
| Country | United Kingdom |
| Organizer | Alzheimer's Association |
| Official Event Website | alz.org/aaic |
| Event Type | Scientific conference, medical research meeting, clinical innovation forum, pharma/biotech networking event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness; Business Services |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Medium. The event is widely recognized as a major global dementia and Alzheimer’s research conference, but current-year attendance is not publicly confirmed here. |
| Main Purpose of Event | To share scientific advances in Alzheimer’s and dementia research, clinical practice, diagnostics, therapeutics, caregiving, and translational innovation, while enabling collaboration across academia, healthcare, industry, and public-sector stakeholders. |
The Alzheimer's Association International Conference (AAIC) is one of the most important annual gatherings dedicated to Alzheimer’s disease and dementia research. It brings together scientists, clinicians, pharmaceutical and biotech teams, diagnostic innovators, public-health stakeholders, and care-focused organizations to present research, discuss clinical pathways, and explore evidence-based approaches to diagnosis, treatment, and patient support.
From a business and lead-generation perspective, AAIC is highly relevant because it concentrates decision-makers involved in research funding, trial design, therapeutic development, diagnostics, digital health, care delivery, and institutional collaboration. For B2B outreach, the event is strongest for companies selling to life sciences, healthcare providers, academic research centers, government health bodies, and commercial teams involved in neurodegeneration and aging-related innovation.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Pharmaceutical R&D teams | Large pharma, specialty pharma, CNS-focused companies | Influence on drug discovery, clinical trials, partnerships, and vendor selection | High relevance for therapeutics, biomarker, CRO, data, and research service providers |
| Biotech executives and scientific teams | Biotech developers, platform technology firms, startups | Decision-making on partnerships, funding, and technical collaboration | Strong target for assay, lab, AI, and translational research suppliers |
| Clinical researchers and investigators | Universities, academic medical centers, research hospitals | Protocol design, study selection, and research collaboration influence | High value for trial management, analytics, imaging, and lab technology vendors |
| Hospital and memory clinic leaders | Hospitals, neuro clinics, memory care centers | Influence on care pathways, diagnostics, procurement, and service adoption | Relevant for diagnostics, care software, monitoring, and patient-management tools |
| Diagnostics and laboratory leaders | IVD companies, pathology labs, biomarker labs | Buying authority for assays, platforms, reagents, and lab services | High relevance for diagnostic and lab technology providers |
| Government and public-health stakeholders | Health ministries, national institutes, public research bodies | Funding, policy, procurement, and program influence | Important for grant-support, health-data, policy, and research infrastructure suppliers |
| CROs and clinical operations teams | Contract research organizations, trial vendors | Influence on outsourced research services and technology adoption | Highly relevant for patient recruitment, eClinical, data, and trial operations tools |
| Patient advocacy and nonprofit leaders | Alzheimer’s associations, caregiving nonprofits, foundations | Program influence, funding partnership, community engagement | Relevant for fundraising, education, awareness, and patient-support solutions |
| Technology and data leaders | Digital health firms, AI companies, informatics groups | Tool selection for analytics, AI, imaging, data integration, and workflow | Relevant for software, AI, cloud, interoperability, and cybersecurity vendors |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: London | Local hospitals, universities, biotech firms, research networks, and healthcare innovators | Medium | London is a major life sciences and research hub with strong healthcare and academic participation. |
| Host region: England / UK | National research institutes, NHS organizations, universities, pharma and medtech firms | High | Strong domestic reach due to the UK’s concentration of neuroscience, aging, and medical research institutions. |
| Nearby business hubs | Cambridge, Oxford, Cambridge-London corridor, Greater South East England | High | These hubs are especially relevant for biotech, medtech, and academic research attendance. |
| Europe | Pharma, biotech, hospitals, public-health bodies, and research groups | High | The London location supports strong continental European attendance. |
| North America | US and Canadian pharma, biotech, NIH-linked researchers, hospitals, nonprofits | Very High | AAIC is historically North America-heavy even when held outside the US. |
| Global / international | Multinational life sciences organizations, universities, NGOs, and health agencies | Very High | The conference has broad international relevance across Alzheimer’s and dementia ecosystems. |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | AAIC is an international scientific conference with participation relevance across North America, Europe, and other major research markets. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Alzheimer's Association | Organizer / nonprofit / research-funding body | Hosts the conference and drives the largest dementia research network | alz.org | Conference Director, Program Director, Research Leadership, Partnerships | Confirmed Speaker Organization |
| National Institute on Aging (NIA) | Government / research funder | Major funder and policy influencer in aging and dementia research | nia.nih.gov | Program Officer, Grants Manager, Director, Scientific Review | Confirmed Government / Procurement Organization |
| UK Dementia Research Institute | Research institute | UK-based dementia research center likely to participate in London-hosted conference | ukdri.ac.uk | Director, Principal Investigator, Research Manager, Partnerships | Strong Market Fit, Attendance Not Confirmed |
| Biogen | Biopharma | Neurology and neurodegeneration-focused commercial and scientific stakeholder | biogen.com | VP Medical Affairs, Clinical Development, Business Development, Market Access | Strong Market Fit, Attendance Not Confirmed |
| Eisai | Pharmaceutical company | Active in Alzheimer’s therapeutics and a highly relevant scientific-commercial prospect | eisai.com | Medical Affairs Director, Clinical Ops, R&D, Partnerships | Strong Market Fit, Attendance Not Confirmed |
| Eli Lilly and Company | Pharmaceutical company | Large neuroscience and therapeutic development organization | lilly.com | Director Clinical Development, Medical Affairs, Research, BD | Strong Market Fit, Attendance Not Confirmed |
| Roche | Pharma / diagnostics | Relevant across diagnostics, biomarkers, and therapeutics | roche.com | Diagnostics Director, R&D, Clinical Strategy, Partnerships | Strong Market Fit, Attendance Not Confirmed |
| AbbVie | Pharmaceutical company | Therapeutics and neuroscience investment interest make it a strong prospect | abbvie.com | VP R&D, Medical Affairs, Procurement, External Innovation | Strong Market Fit, Attendance Not Confirmed |
| Johnson & Johnson | Healthcare / medtech / pharma | Broad healthcare innovation exposure and potential collaboration interest | jnj.com | Innovation Lead, Clinical Strategy, Medical Affairs, Partnerships | Strong Market Fit, Attendance Not Confirmed |
| Novo Nordisk | Pharmaceutical company | Metabolic-health and neuroscience-adjacent strategic relevance | novonordisk.com | Clinical Development, Medical Affairs, Research, Partnering | Strong Market Fit, Attendance Not Confirmed |
| Pfizer | Pharmaceutical company | Large commercial and clinical organization with neurology and R&D relevance | pfizer.com | R&D Director, Medical Affairs, Alliance Management, Procurement | Strong Market Fit, Attendance Not Confirmed |
| NHS England | Government health system / buyer | Relevant for dementia pathways, care models, service procurement, and adoption | england.nhs.uk | Clinical Lead, Procurement, Transformation Director, Programme Manager | Strong Market Fit, Attendance Not Confirmed |
| Alzheimer's Research UK | Nonprofit / research funder | Major UK dementia research and advocacy organization | alzheimersresearchuk.org | Research Director, Fundraising, Partnerships, Policy Lead | Strong Market Fit, Attendance Not Confirmed |
| University of Cambridge | Academic research institution | Leading neuroscience and biomedical research center in the UK | cam.ac.uk | PI, Research Director, Grants Manager, Partnerships | Strong Market Fit, Attendance Not Confirmed |
| University of Oxford | Academic research institution | Key UK research hub for translational science and clinical research | ox.ac.uk | Professor, Clinical Research Lead, PI, Technology Transfer | Strong Market Fit, Attendance Not Confirmed |
| Mass General Brigham | Healthcare system / research hospital | Large US academic medical network with strong neuroscience research relevance | massgeneralbrigham.org | Director Research, Clinical Operations, Procurement, Innovation | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | VP / Director of R&D | Research & Development | VP / Director | Owns scientific strategy, partnership evaluation, and vendor alignment. |
| 2 | Chief Medical Officer / Medical Affairs Leader | Medical Affairs | C-level / VP | Influences clinical strategy, evidence generation, and market adoption. |
| 3 | Clinical Development Director | Clinical Development | Director | Leads trial design, site strategy, and research vendor engagement. |
| 4 | Principal Investigator / Professor | Academic Research | Senior | Key scientific authority and collaborator for studies, grants, and publications. |
| 5 | Head of Biomarkers / Translational Research | Translational Science | Director / Head | Strong buyer for assays, data platforms, and lab innovations. |
| 6 | Director of Diagnostics / Laboratory Services | Diagnostics / Lab | Director | Evaluates platforms, workflows, and lab procurement. |
| 7 | Program Manager / Research Manager | Research Operations | Manager | Coordinates studies, vendor inputs, and conference networking. |
| 8 | Director of Digital Health / Informatics | Digital / IT / Informatics | Director | Potential buyer for data, AI, workflow, and integration solutions. |
| 9 | Procurement / Strategic Sourcing Manager | Procurement | Manager / Director | Relevant for buying services, tools, and research infrastructure. |
| 10 | Partnerships / Business Development Director | Corporate Development | Director / VP | Drives external innovation, licensing, and alliance creation. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Pharmaceuticals | Core commercial audience for Alzheimer’s therapeutics and pipeline strategy | R&D, clinical, medical affairs, partnering |
| 2 | Biotechnology | Highly relevant for biomarker, platform, and translational innovation companies | Scientific collaboration, vendor sourcing, partnerships |
| 3 | Hospital & Health Care | Major audience for diagnostics, care delivery, and patient management | Clinical adoption, workflow tools, care programs |
| 4 | Research | Academic and translational research is central to AAIC | Grant support, instruments, data, services |
| 5 | Medical Devices | Relevant for diagnostics, monitoring, imaging, and supportive care products | Clinical tools and diagnostic equipment |
| 6 | Information Technology & Services | Data, interoperability, AI, and digital health are increasingly relevant | Analytics, cloud, AI, patient data systems |
| 7 | Biotechnology / Life Sciences | Key for research partnerships and innovation scouting | Platform sales, lab services, collaborative R&D |
| 8 | Government Administration | Public-sector funding, health policy, and research program buyers attend or engage | Public health, grant-funded solutions, policy support |
| 9 | Nonprofit Organization Management | Patient advocacy and fundraising organizations are highly relevant | Education, campaigns, donor tools, services |
| 10 | Health, Wellness & Fitness | Relevant to care, prevention, and aging support stakeholders | Care programs, digital support, patient engagement |
| 11 | Management Consulting | Advisory firms support life sciences strategy, access, and transformation | Strategic partnerships, market access, operations |
| 12 | Computer Software | Relevant for research platforms, AI, workflow, imaging, and data systems | SaaS, analytics, AI, research informatics |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Several thousand attendees | Estimated | Market reputation and historical conference scale | Attendance figure not publicly confirmed by the organizer. |
| Exhibitor count | Not publicly confirmed | Not confirmed | Organizer information not verified here | Use official exhibitor prospectus or floorplan when available. |
| Buyer count | Not publicly confirmed | Not confirmed | No current-year buyer list publicly verified here | Likely mixed scientific, clinical, and commercial audience. |
| Speaker count | Not publicly confirmed | Not confirmed | Official agenda should be checked for the final 2026 program | AAIC typically features a large scientific program. |
| Historical attendance evidence | Major global annual meeting | Historical / prior-year evidence | Prior-year conference reputation and recurring annual scale | Suitable for attendee-list building and senior stakeholder targeting. |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Clinical trials | Patient recruitment, site management, protocol execution | Engage trial ops and clinical development teams | CRO services, eClinical tools, recruitment solutions |
| Biomarkers and diagnostics | Earlier detection, validation, lab workflow | Target translational and lab leaders | Assays, instrumentation, reagent platforms, lab software |
| Therapeutics and drug development | Pipeline advancement and evidence generation | Target R&D, medical affairs, and partnering teams | Research services, data platforms, consulting, analytics |
| Digital health and AI | Decision support, image analysis, digital biomarkers, workflow tools | Target IT, informatics, and innovation teams | AI software, cloud, interoperability, analytics |
| Care delivery and patient support | Improved care pathways, monitoring, caregiver support | Target hospital, clinic, and nonprofit leaders | Patient engagement, remote monitoring, care management tools |
| Research funding and grants | Programs, grants, scientific collaboration | Target nonprofits, universities, public agencies | Grant support, project management, research administration tools |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The event attracts pharma, biotech, research, clinical, and public-sector decision-makers. |
| Decision-maker availability | High | Strong concentration of directors, VPs, principal investigators, and program leads. |
| Data collection potential | High | Conference programs, speakers, sponsors, and exhibitors can support targeted list-building. |
| Apollo targeting potential | Very High | Clear industry, title, and geography filters exist across life sciences, healthcare, and research. |
| Geographic targeting potential | High | Strong UK, Europe, North America, and global appeal provides flexible territory segmentation. |
| Best outreach approach | Account-based outreach + title-based prospecting | Prioritize organizations in pharma, biotech, research, diagnostics, and health systems. |
| Overall lead quality | Very High | AAIC is a premium conference for specialized, high-value B2B audiences. |
| Best use case | Attendee list sales, sponsor prospecting, and high-intent outreach | Best for vendors serving research, clinical, diagnostic, and healthcare decision-makers. |
| Limitations / risks | Moderate | Many attendees are scientific rather than commercial buyers; current-year attendee confirmation may be limited. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Pharmaceuticals, Biotechnology, Hospital & Health Care, Research, Medical Devices, Information Technology & Services, Government Administration, Nonprofit Organization Management, Management Consulting | Align to the most likely commercial and institutional attendees. |
| Departments | R&D, Clinical Development, Medical Affairs, Procurement, Partnerships, Product, Innovation, Research Operations, IT / Informatics | Reach both scientific and buying stakeholders. |
| Seniority | Manager, Director, VP, CXO, Head, Principal, Lead | Prioritize decision-makers and high-influence contributors. |
| Job titles | VP R&D, Director of Clinical Development, Medical Affairs Director, Principal Investigator, Research Director, Program Manager, Procurement Manager, Partnerships Director, Innovation Lead, Head of Biomarkers | Match high-fit titles typically associated with AAIC attendance and influence. |
| Geography | United Kingdom, Ireland, Western Europe, United States, Canada, Nordics, Benelux, Switzerland | Captures the most relevant international research and pharma markets. |
| Employee size | 51–200, 201–500, 501–1,000, 1,001–5,000, 5,001–10,000, 10,000+ | Useful across startups, scale-ups, hospitals, universities, and large pharma. |
| Keywords | Alzheimer's, dementia, neurology, neuroscience, biomarkers, clinical trials, cognitive decline, memory clinic, neurodegeneration, diagnostics, translational research | Narrows searches to the most event-relevant functions and organizations. |
| Company type | Public, private, nonprofit, university, hospital system, government agency | Reflects the event’s mixed scientific-commercial attendee base. |
| Revenue range | Any, but prioritize mid-market and enterprise for commercial vendors | Commercial suppliers will usually see strongest ROI from larger accounts. |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Alzheimer's Association International Conference (AAIC) official website | Official organizer source | Event identity, organizer, conference purpose, and official annual conference positioning | High |
| Alzheimer's Association | Organizer website | Organizer background and conference ecosystem relevance | High |
| ExCeL London | Venue website | Venue identity and London event location | High |
| National Institute on Aging | Government agency page | Public-sector relevance to aging and dementia research buyers | High |
| UK Dementia Research Institute | Research institution | UK dementia-research market context and likely attendee relevance | Medium |
| NHS England | Government health system page | Clinical adoption and procurement relevance in the host country | Medium |
| Alzheimer's Research UK | Association / nonprofit | UK nonprofit research and advocacy relevance | Medium |
| Event description supplied by user | User-provided reference | Confirmed date, venue, city, region, country, and event positioning used in this report | Medium |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Alzheimer's Association International Conference (AAIC) 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.